Also appoints Scott Bruder, MD, PhD as its Chairman of the Board of Directors
Marietta, GA – June 30, 2016 – Amendia, Inc., a leading designer, developer, manufacturer and marketer of medical devices used in spinal surgical procedures, today announced that Chris Fair, its current Chief Operating Officer, has been named President and Chief Executive Officer. Additionally, Amendia announced the appointment of Scott Bruder, MD, PhD, a current Amendia Director, to be the Chairman of its Board of Directors.
Mr. Fair assumes the CEO position from Amendia founder Jeff Smith, who will continue with Amendia as a key part of its leadership team, as Chairman of the Executive Committee. Mr. Smith will also remain one of Amendia’s largest shareholders. The Executive Committee will comprise Mr. Smith, Mr. Fair, Dr. Bruder, and representatives of Kohlberg & Company, Amendia’s financial partner.
“I couldn’t be prouder to see Amendia attract world-class leaders like Chris and Scott,” commented Mr. Smith. “Chris and Scott are strong believers in Amendia’s mission and are enthusiastic about building on our core value proposition, including our vertically-integrated business model and our focus on improving surgical outcomes and the lives of patients with spinal disorders. I am excited for my new role as it will allow me to work closely with experienced spine professionals like Chris and Scott and continue to support Amendia’s future success, while focusing my energy on the areas of the business where my passions burn brightest and my impact on Amendia’s mission can be most meaningful.”
Chris Fair joined Amendia as its Chief Operating Officer in April 2016. Mr. Fair has 25 years of spine industry experience, including a decade at DePuy Spine and leading Sales & Marketing at St. Francis Medical prior to its acquisition by Kyphon. Mr. Fair also worked with Amendia in a consulting role over the last five years prior to joining the company in a full time employee role earlier this year.
Scott Bruder, MD, PhD has 30 years of relevant corporate, scientific and clinical experience, including past positions as Chief Medical & Scientific Officer of Stryker Corporation, Chief Science & Technology Officer of Becton, Dickinson & Company, and Worldwide Vice President at DePuy Spine. He is a Professor of Orthopaedic Surgery and Biomedical Engineering at Case Western Reserve University, and has served on Advisory Panels at FDA, various Committees in the Orthopaedic Research Society and the American Academy of Orthopaedic Surgeons, and the Board of Directors of several other privately held or public MedTech companies.
“I am honored to have been selected for this role and I thank Jeff Smith and the Amendia management team and Board of Directors for their confidence in me,” commented Mr. Fair. “I could not be more energized about what lies ahead for us as a company. Our potential for the future is extraordinary, and I am excited to lead the strong and passionate team of Amendia employees and partners forward to achievement of our goals.”
“Since joining the Amendia Board of Directors, I have been thoroughly impressed with the company’s broad product portfolio, deep pipeline of innovative products and technologies in development, and passionate employee base committed to delivering clinically meaningful solutions and superior customer service,” commented Dr. Bruder. “I look forward to working closely with the Amendia executive team to build on the company’s strong foundation and deliver maximum value to Amendia’s current and future customers and partners.”
Headquartered in an integrated design and manufacturing facility in Marietta, GA, Amendia is a leading designer, developer, manufacturer and marketer of medical devices used in spinal surgical procedures. Amendia’s mission is to exceed surgeon and patient expectations by creating balanced solutions with disruptive technologies for medical devices paired with biologics and instrumentation. Amendia offers a full suite of products to address the deformity and degenerative market segments, as well as minimally invasive and biologic solutions to treat even the most challenging cases. The company markets and sells its products through direct sales employees, independent agencies, and distributor partners. For more information, please visit www.amendia.com.
Nikki Coleman, VP-Marketing & Education